Existing investor Bloomberg Beta came back to invest in the data science platform developer, after contributing to a $3m round last year.

Pharmaceutical company Chiesi Group's strategic investment unit has become an investor in Glycomine, which develops replacement therapies for rare diseases.

Dell Ventures returned to back Invincea, developer of an anti-malware product called X by Invincea, having co-led its $16m series C round.

Cloud computing technology developer AllMobilize had raised $10m in a June 2015 series B round that featured IDG Capital Partners.

The artificial intelligence and machine learning development platform expects to send its first products to market early next year.

Stanford University-funded accelerator StartX was an investor in the round, which was co-led by Mayfield and Norwest Venture Partners.

Global Sources and existing backers Swisscom and ZKB were among the investors in the fertility tracking wristband maker's latest round, which has been closed at $9.7m.

The cybersecurity software startup, a graduate of Microsoft Accelerator in Tel Aviv, closed a $10m round just nine months after raising $4m in seed funding.

The Intel Capital-backed web content monitoring platform has secured $13m in a round that could close nearer to $18m, according to a securities filing.